12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tresiba insulin degludec regulatory update

Novo Nordisk said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Tresiba insulin degludec to treat Type I and Type II diabetes. Novo Nordisk expects to launch Tresiba in Japan when price negotiations...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >